In the current month, JAGX has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. JAGX average Analyst price target in the last month is 16.000.
Based on analysts' estimates, JAGX EPS is projected to reach -1.170 in FY2026Q3, following reported EPS of -235.459 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -235.46, while Jaguar Health IncJAGX's earnings per share (EPS) for the previous quarter was USD -13.60. EPS for the next quarter is expected at USD -1.17.